Nidan Laboratories and Healthcare Approves FY 2026 Results, Reappoints Key Directors and Auditors

Nidan Laboratories and Healthcare Approves FY 2026 Results, Reappoints Key Directors and Auditors​

Nidan Laboratories and Healthcare Limited announced the outcome of its Board of Directors meeting held on May 25, 2026. During the meeting, the Board approved the Audited Financial Results for the financial year ending March 31, 2026, alongside key corporate governance decisions, including the re-appointment of independent directors and statutory auditors.

Financial Highlights for FY 2026​

The Company released its detailed financial results for the year ended March 31, 2026, showing significant operational figures.

The statement of assets and liabilities revealed the following comparative figures (amounts in Rs lakhs):

Profit and Operational Performance​

The Company's performance metrics are detailed in the comparative statements. For the financial year ended March 31, 2026, Total Income from Operations stood at 2,554.16 Rs lakhs, compared to 2,452.75 Rs lakhs in the previous year. The Profit for the year ended March 31, 2026, was 150.60 Rs lakhs.

The Net Profit for the period / year after tax for the year ended March 31, 2026, was 150.60 Rs lakhs.

Governance Appointments​

The Board meeting also approved several key corporate governance re-appointments:

1. Independent Directors Re-appointment: The Board re-appointed two directors for a second term of five years, effective August 20, 2026:
* Mr. Nilesh Bide (DIN: 06366702): Re-appointed as a Non-Executive-Independent Director. He possesses qualifications as a post graduate architect and has over 22 years of interest in planning and operation of healthcare centers.
* Mr. Abhinay Nerurkar (DIN: 09250964): Re-appointed as a Non-Executive-Independent Director. He brings over 20 years of professional experience, with core competence in managing Profit & Loss.

2. Statutory Auditors Re-appointment: M/s R. K. Chapawat & Co., Chartered Accountants (FRN 101708W) were re-appointed as the Company's Statutory Auditors for a further period of 5 years.

Audit Confirmation​

The statutory auditors, M/s R. K. Chapawat & Co., Chartered Accountants, issued an Audit Report confirming that the financial results of Nidan Laboratories and Healthcare Limited for the half year ended March 31, 2026, and for the year ended March 31, 2026, are presented in accordance with applicable standards and give a true and fair view.

***
Note: The company's Board of Directors commenced the meeting at 12:30 Hrs and concluded at 17:15 Hrs on Monday, May 25, 2026.

NIDAN Stock Price Movement​

Nidan Laboratories and Healthcare Limited shares today gained 4.18% in post-market trading, settling at ₹14.95. The stock saw notable buying interest, recording a total volume of 12,000 shares for the session.